Home / People / Dr. Hendrik Hirsch
Portrait ofHendrik Hirsch

Dr. Hendrik Hirsch

Partner
Rechtsanwalt

CMS Hasche Sigle
Neue Mainzer Straße 2–4
60311 Frankfurt
Germany
Languages German, English, Spanish

Hendrik Hirsch focuses on corporate law and mergers and acquisition. He has more than 15 years of experience in advising national and international clients on cross-border as well as domestic transactions. This includes sell side and buy side mandates as well as advice on joint ventures, restructurings and corporate law matters. Since 2015, Hendrik has been heading the excellence cluster "Industry and M&A" at CMS.

Hendrik joined CMS in 2001 and has been a partner since 2007.

more less

„Oft empfohlen“ für Private Equity und Venture Capital

JUVE Handbuch, 2023/2024

„Oft empfohlen“ für M&A

JUVE Handbuch, 2023/2024

Listed for Private Equity

Deutschlands beste Anwälte 2023 – Handelsblatt in Kooperation mit Best Lawyers

Listed for Mergers and Acquisitions

Deutschlands beste Anwälte 2023 – Handelsblatt in Kooperation mit Best Lawyers

"Recommended" for Private Equity and Venture Capital, M&A

JUVE German Commercial Law Firms 2020-2022 (GCLF)

Publications

  • Der Erwerb eigener Aktien - unter Berücksichtigung der Bilanzierung eigener Aktien, 2004
  • Der Squeeze-Out - ein neues Rechtsinstitut im Aktienrecht, CMS-Report 2002
  • Voraussetzung des Widerrufs eines Bestätigungsvermerks, Die Wirtschaftsprüfung 2001, p. 606 f
more less

Education

  • 1999 - 2001: Trainee lawyer in Berlin, including placements at CMS Germany and the Berlin Court of Appeal
  • 1997/1998: Doctorate under the supervision of Dr Peter Hommelhoff (1997/1998) with a Ph.D. scholarship of Arbeitskreises Wirtschaft und Recht im Stifterverband für die Deutsche Wissenschaft
  • Until 1997: Law studies in Heidelberg, research assistant at the Institute for Financial Sciences (Prof. Manfred Rose)
  • 1993 - 1994: Studies abroad at Carleton University / Ottawa, Canada
  • 1991 - 1993: Law studies in Heidelberg
more less

Feed

29/02/2024
CMS advises Bobst Group on sale of minority stake in BHS Group
Frankfurt am Main – Bobst Group SA, a leading global supplier of equipment and services to the packaging industry, has sold its long-standing minority stake of 30% in BHS Corrugated Maschinen- und Anlagenbau GmbH. The transaction sees the majority shareholder, BWV-Well­pap­pen­maschinen Vertriebs-GmbH, acquiring the equity interest back from Bobst Group SA and increasing its majority stake in the BHS Group.A CMS team headed by Dr Hendrik Hirsch advised Bobst Group SA on all legal aspects of the transaction. Ahead of the transaction, CMS also provided Bobst Group SA with comprehensive corporate law advice on its minority stake. Bobst Group SA is based in the Swiss city of Lausanne and is one of the world’s leading suppliers of equipment and services for substrate production, printing and processing. Its customers include the label, flexible packaging, folding box and corrugated board industries. The group generated sales of around CHF 2 billion in 2023. BHS Corrugated Maschinen- und Anlagenbau GmbH is a global supplier of mechanical engineering, plant engineering, lifecycle services and digital solutions for the corrugated board industry. It is headquartered in the Bavarian town of Weiherhammer. CMS Germany Dr Hendrik Hirsch, Partner Dr Maximilian Stark, Senior Associate, both Corporate/M&A Dr Jan Schepke, Partner Dr Armin Dürrschmidt, Partner Marcus Weiler, Senior Associate Dr Philipp Koch, Counsel, all Corporate Stefan Lehr, Partner, Antitrust, Competition & TradePress Con­tact presse@cms-hs. com
28/02/2024
CMS advises Bruker on the multi-jur­is­dic­tion­al acquisition of ELITech,...
Frankfurt/Main – Bruker has agreed to acquire ELITechGroup, a provider of specialty in vitro diagnostic (IVD) systems, from TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, for EUR 870 million in cash, excluding the carved out ELITech clinical chemistry business. The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals and other customary closing conditions.A team of CMS Germany headed by lead partner Dr Hendrik Hirsch acted as lead transaction counsel on this landmark transaction for Bruker's MDx business covering all M&A aspects of the transaction, IVDR and other regulatory aspects, antitrust and FDI filings, the carve out of the clinical chemistry business and support on the employee consultation processes in France and the Netherlands. ELITechGroup, with over 500 employees and over 40 active patents, develops and commercializes innovative, proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and microbiology products. Its molecular diagnostic business accounts for the majority of the to-be-acquired revenues and provides the unique sample-to-answer (S2A) instruments InGenius® and Be-Genius® in the mid-to-high throughput MDx category with PCR diagnostic assays for infections and diseases. ELITechGroup, excluding the clinical chemistry business, achieved approximately EUR 150 million in revenues in 2023. ELITechGroup generates the majority of its revenues from Europe, with significant business also in North and Latin America. Its major R&D and production sites are in Italy, the United States, France and Germany. CMS Germany Dr Hendrik Hirsch, Partner, Co-Lead Dr Jacob Siebert, Partner, Co-Lead Dr Dirk Baukholt, Principal Counsel Dr Berrit Roth-Mingram, Counsel Dr Maximilian Stark, Senior Associate, all Corporate/M&A Dr Roland Wiring, Partner Lukas Burgdorff, Associate Noah Rodenkirchen, Associate, all Regulatory & Lifesciences Dr Thomas Hirse, Part­ner Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Dr Michael Bauer, Partner Stefan Lehr, Partner Kai Neuhaus, Partner Moritz Pottek, Counsel Dr. Denis Schlimpert, Counsel Kirsten Baubkus-Gerard, Senior Associate David Rappenglück, As­so­ci­ate Be­ne­dikt Christian Voss, Associate, all Antitrust, Competition & Trade Dr Thomas de la Motte, Partner Dr Markus Pfaff, Partner Dr André Frischemeier, Partner Hatice Aykel, Counsel Alisa Brehm, Senior Associate Thomas Schaak, Senior Associate Dr Sait Dogan, Associate, all Banking & Finance  Dr André Lippert, Part­ner Con­stan­ze Schweidtmann, Associate, both Real Estate & Public Dr Boris Alles, Partner Dr Theresa Kipp, Senior Associate, both Labor, Employment & Pensions CMS France Benoît Gomel, Partner Vincent Desbenoit, Associate Dylan Allali, all Corporate/M&A Caroline Froger-Michon, Partner Aurélie Parchet, As­so­ci­ate Ca­m­ille Baumgarten, Associate Sophie Yin, all Em­ploy­ment Claire Vannini, Partner Eleni Moraïtou, Coun­sel Lilia-Ori­ana Dif, Associate Ariane Rolin, all Competition & EU  Jean-Bap­tiste Thiénot, Partner Anaïs Arnal, Associate, both Intellectual Property Laurine Mayer, Associate, TMC Alexandre Chazot, Counsel, Banking & Fin­ance  Thi­erry Granier, Partner Renaud Grob, Partner, both Tax Arnaud Valverde, Senior Associate, Real Estate Olivier Kuhn, Partner Cécile Rebiffé, Counsel Mylène Garrouste, all Dispute Res­ol­u­tion Kawthar Ben Khelil, Coun­sel Jean-Pierre Malili, Associate, both Public law/In­fra­struc­ture CMS Italy Massimo Trentino, Partner, Corporate/M&A Maria Letizia Patania, Partner, Lifescience & Healthcare Gian Marco Lettieri, Senior Associate, Employment & Pensions Giulio Poggioli, Counsel Valerio Giuseppe Daniele, As­so­ci­ate Francesca Durante, Junior As­so­ci­ate  Arianna Toccaceli, Junior Associate, all Banking & Finance CMS Luxembourg Gérard Maitrejean, Partner Miruna Poenaru, Coun­sel Max­imili­an Helfgen, Associate, all Corporate/M&A CMS UK Jack Letson, Partner Lindsay McAllister, Associate, both Corporate/M&A David Dennis, Partner, Commercial CMS Netherlands Pieter van Duijvenvoorde, Partner Robert Jong, both Corporate/M&A Nigel Henssen Fleur van Assendelft de Coningh, both Employment Edmon Oude Elferink, Partner Marijke van der Vossen, both Antitrust, Competition & Trade CMS Serbia Radivoje Petrikić, Partner Mila Drljević, both Corporate/M&A CMS Austria Dieter Zandler, Partner Vanessa Horaceck, both Competition & EU CMS Ukraine Maria Orlyk, Partner Diana Valyeyeva CMS Turkiye Döne Yalçın, Partner Arcan Kemahlı,  Sa­ba­hat­tin Öztemiz Taner ElmasPress Con­tact presse@cms-hs. com
08/02/2024
International CMS team advises provider of safety-related automation solutions...
Frankfurt/Main – The HIMA Group, based in Brühl in Baden-Württem­berg, one of the leading providers of safety-related automation solutions for the process and rail industry, has acquired Origo Solutions AS. The Norwegian target company is recognized as a market leader in safety, automation and instrumentation systems for monitoring, control and protection of offshore and onshore installations in Norway and internationally for complete SCADA systems for the renewable energy sector. The technology company has more than 40 years’ of experience. For more than 20 years, Origo Solutions has been HIMA's exclusive representative in Norway. With this transaction, both companies intend to continue their growth strategies and expand their range of solutions for the process industry and renewable energies. Main focus here is the digitalisation of functional safety. For HIMA, the acquisition is another important step in the strategic development of the HIMA Group following the expansion in the UK, which was completed in 2023. Origo Solutions was previously owned by Moreld AS (60,1 %) and Aker Capital AS (39,9 %) and a part of the Moreld Group, a leading industrial multi-dis­cip­lin­ary engineering group in Norway. The agreement was signed on 8 January and is effective as of 31 January. The parties involved have agreed not to disclose further details of the transaction.A cross-border CMS team from Germany and Norway headed by lead partner Dr Hendrik Hirsch and Lead Counsel Dr Berrit Roth-Mingram advised HIMA on all legal aspects of the acquisition. Dr Hendrik Hirsch is the Client Relationship Partner for HIMA. The safety specialist regularly relies on the expertise of CMS, most recently on the acquisition of the British system integrator Sella Controls. Press Con­tact presse@cms-hs. com
31/10/2023
GP-led secondary: CMS advises HQ Direct on investment by Verdane in HQ...
Frankfurt/Main – As part of an offer to the investors in the current HQ Equita Fonds V fund, European specialist growth investor Verdane has acquired a significant stake in the portfolio of HQ Equita...
11/10/2023
CMS advises US technology company Bruker on entering into equity-based...
Frankfurt/Main – Bruker Corporation, a NASDAQ-listed US tech company, has acquired a majority stake in MIRO Analytical AG, an innovative provider of fast, compact Quantum Cascade Laser (QCL)-based multi-gas...
17/08/2023
CMS advises SaaS provider F24 Nordics on acquisition of service messaging...
Frankfurt/Main – F24 Nordics AS, a Scandinavian unit of the F24 Group, has acquired Blue Idea ApS, a leading SaaS provider for service messaging in the Nordic countries. The F24 Group is a leader in...
13/06/2023
CMS advises fund managed by private equity firm ECM on acquisition of ONE...
Frankfurt/Main – German Equity Partners V (“GEP V” or the “Fund”) has taken an equity interest in the Düs­sel­dorf-based talent acquisition platform ONE HIRING Group (“1H”) through a partnership...
08/05/2023
CMS advises US technology company Bruker on acquisition of ZONTAL to further...
Frankfurt/Main – Bruker Corporation, a NASDAQ-listed US tech company, has acquired a majority stake in the ZONTAL Group. Based in Germany, the US and China, ZONTAL is a leading provider of data platforms...
28/02/2023
CMS advises European greentech venture Gauss Fusion on EUR 8 million pre-seed...
Frankfurt/Main – Gauss Fusion GmbH, a green venture in the fusion technology sector based in Hanau, has raised around EUR 8 million in an initial pre-seed round of financing. Gauss Fusion is an initiative...
17/02/2023
CMS advises DPE Deutsche Private Equity on sale of VTU Group to Altor Funds
Frankfurt/Main – Funds advised by DPE Deutsche Private Equity have sold the VTU Group to Altor Funds, with the VTU management team likewise selling its interest in the company. DPE is an independent...
09/02/2023
CMS advises private equity firm Pinova Capital on acquisition of Riepe
Frankfurt/Main – Funds advised by Pinova Capital, an independent private equity firm focusing on high-growth SMEs, have acquired Riepe GmbH & Co. KG from the owners, the Riepe family, by way of a management...
02/02/2023
International CMS team advises automation company HIMA on acquisition of...
Frankfurt/Main – The HIMA Group has acquired UK system integrator Sella Controls, including its subsidiaries, with effect from 1 February 2023. HIMA specialises in safety-related automation solutions...